Evidence map›Paper›PMID 42181440›Full record

ArticleCureus2026

A Hidden Shunt Behind Post-COVID-19 Dyspnea: Partial Anomalous Pulmonary Venous Connection.

John Bajouka, Ziad R Affas, Johnathan Stephan, Patrick Alexander

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John BajoukaInternal Medicine, Henry Ford Health System, Southfield, USA.
Ziad R AffasCardiology, Henry Ford Health System, Southfield, USA.
Johnathan StephanCardiology, Henry Ford Health System, Southfield, USA.
Patrick AlexanderCardiology, Henry Ford Health System, Southfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent exertional dyspnea following SARS-CoV-2 infection is frequently attributed to post-viral pulmonary pathology. When symptoms are accompanied by right ventricular (RV) dilation and pulmonary hypertension without elevated left-sided filling pressures, alternative etiologies including congenital heart disease must be considered. A 52-year-old man with prior COVID-19 pneumonia presented with one year of progressive exertional dyspnea. Transthoracic echocardiography demonstrated preserved left ventricular systolic function with RV dilation. Right heart catheterization revealed mild precapillary pulmonary hypertension with a significant oxygen saturation step-up at the superior vena cava-right atrial level. Cardiac computed tomography angiography confirmed partial anomalous pulmonary venous connection (PAPVC) with a sinus venosus atrial septal defect. This case emphasizes the necessity of maintaining a broad differential in patients with persistent dyspnea following COVID-19, cautioning against anchoring bias toward post-viral sequelae. While initial suspicion focused on Group 3 pulmonary hypertension, the findings of RV dilation and a normal pulmonary capillary wedge pressure mandated further investigation. This suggests that the acute pulmonary insult may have physiologically unmasked a previously compensated, hemodynamically significant PAPVC. Ultimately, the integration of invasive hemodynamics, specifically identifying an oxygen saturation step-up, and multimodality imaging is essential to identify rare but correctable congenital anomalies in adults presenting with non-specific respiratory complaints.

Indexed as

covid 19oxygen saturation step-uppartial anomalous pulmonary venous connectionright heart catheterizationsinus venosus atrial septal defect

Identifiers

PMID42181440
PMCPMC13193273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.